Interindividual differences in placental expression of the SLC22A2 (OCT2) gene: Relationship to epigenetic variations in the 5'-upstream regulatory region

Journal of Pharmaceutical Sciences

Volumn 100, Issue 9, 2011, Pages 3875-3883

  Saito, Jumpei ^a   Hirota, Takeshi ^a   Kikunaga, Naomi ^a   Otsubo, Kenji ^b   Ieiri, Ichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Chromatin; Membrane transporter; MRNA; Organic cation transporter; Placenta; Polymorphisms

Indexed keywords

HISTONE H3; MESSENGER RNA; ORGANIC CATION TRANSPORTER 2;

5' UNTRANSLATED REGION; ALLELE; ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC VARIABILITY; HISTONE ACETYLATION; HUMAN; PLACENTA; PROMOTER REGION;

EID: 79960120536     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22595     Document Type: Article

References (31)

1. Solter D. 1988. Differential imprinting and expression of maternal and paternal genomes. Annu Rev Genet 22:127-146.
2. Efstratiadis A. 1994. Parental imprinting of autosomal genes. Curr Opin Genet Dev 4:265-280.
3. Vu TH, Li T, Hoffman AR. 2004. Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Hum Mol Genet 13:2233-2245.
4. Nicholls RD. 2000. The impact of genomic imprinting for neurobehavioral and developmental disorders. J Clin Invest 105:413-418.
5. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE. 1993. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362:749-751.
6. Spahn L, Barlow DP. 2003. An ICE pattern crystallizes. Nat Genet 35:11-12.
7. Verona RI, Mann MR, Bartolomei MS. 2003. Genomic imprinting: Intricacies of epigenetic regulation in clusters. Annu Rev Cell Dev Biol 19:237-259.
8. Bourc'his D, Bestor TH. 2006. Origins of extreme sexual dimorphism in genomic imprinting. Cytogenet Genome Res 113:36-40.
9. Zwart R, Sleutel F, Wuts A, Schinkel AH, Barlow DP. 2001. Bidirectional action of the Igf2r imprint control element on upstream and downstream imprinted genes. Genes Dev 15:2361-2366.
10. Killian JK, Byrd JC, Jirtle JV, Munday BL, Stoskopf MK, MacDonald RG, Jirtle RL. 2000. M6P/IGF2R imprinting evolution in mammals. Mol Cell 5:707-716.
11. Riesewijk AM, Schepens MT, Welch TR, van den Berg-Loonen EM, Mariman EM, Ropers HH, Kalscheuer VM. 1996. Maternal-specific methylation of the human IGF2R gene is not accompanied by allele-specific transcription. Genomics 31:158-166.
12. Barlow DP, Stoger R, Herrmann BG, Saito K, Schweifer N. 2001. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84-87.
13. Sleutels F, Zwart R, Barlow DP. 2002. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415:810-813.
14. Stricker SH, Steenpass L, Pauler FM, Santoro F, Latos PA, Huang R, Koerner MV, Sloane MA, Warczok KE, Barlow DP. 2008. Silencing and transcriptional properties of the imprinted AIRN ncRNA are independent of the endogenous promoter. EMBO J 27:3116-3128.
15. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R, Fraser P. 2008. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322:1717-1720.
16. Monk D, Arnaud P, Apostolidou S, Hills FA, Kelsey G, Stanier P, Feil R, Moore GE. 2006. Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci USA 103:6623-6628.
17. Yotova IY, Vlatkovic IM, Pauler FM, Warczok KE, Ambro PF, Oshimura M, Theussl HC, Gessler M, Wargner EF, Barlow DP. 2008. Identification of the human homolog of the imprinted mouse Air non-coding RNA. Genomics 92:464-473.
18. Seidl CM, Stricker SH, Barlow DP. 2006. The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J 25:3565-3575
19. Reik W, Walter J. 2001. Genomic imprinting: Parental influence on the genome. Nat Rev Genet 2:21-32.
20. Lee WK, Wolff NA, Thévenod F. 2009. Organic cation transporters: Physiology, toxicology and special focus on ethidium as a novel substrate. Curr Drug Metab 10:617-631.
21. Salas M, John R, Saxena A, Barton S, Frank D, Fitzpatrick G, Higgins MJ, Tycko B. 2004. Placental growth retardation due to loss of imprinting of Phlda2. Mech Dev 121:1199-1210.
22. Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R. 2005. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14:1049-1058.
23. Hu JF, Hoffman AR. 2001. Examining histone acetlylation at specific genomic regions. Methods Mol Biol 181:285-296.
24. Inamochi Y, Mochizuki K, Osaki A, Ishii T, Nakayama T, Goda T. 2010. Histone H3 methylation at lysine 4 on the SLC2A5 gene in intestinal Caco-2 cells is involved in SLC2A5 expression. Biochem Biophys Res Commun 392:16-21.
25. Calcagno AM, Fostel JM, To KK, Salcido CD, Martin SE, Chewning KJ, Wu CP, Varticovski L, Bates SE, Caplen NJ, Ambudkar SV. 2008. Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer 98:1515-1524.
26. To KK, Polgar O, Huff LM, Morisaki K, Bates SE. 2008. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol Cancer Res 6:151-164.
27. Ahmad K, Henikoff S. 2002. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 9:1191-1200.
28. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H. 1997. Cloning and characterization of two human polyspecific organic cation transporters. DNA cell Biol 16:871-881.
29. Sata R, Ohtani H, Tsujimoto M, Murakami H, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Nagata H, Tsukimori K, Nakano H, Sawada Y. 2005. Functional analysis of organic cation transporter 3 expressed in human placenta. J Pharmacol Exp Ther 315:888-895.
30. Fujita T, Urban TJ, Leabman MK, Fujita K, Giacomini KM. 2006. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 95:25-36.
31. Inui KI, Masuda S, Saito H. 2000. Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58:944-958.